Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07215663
What this trial is testing

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Candid Therapeutics 47
Not applicableStudy completedNCT04580108
What this trial is testing

Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 446
Early research (Phase 1)Active Not RecruitingNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableUnknownNCT06294483
What this trial is testing

Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 100
Early research (Phase 1)Looking for participantsNCT06737380
What this trial is testing

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
SLELupusSystemic Lupus Erthematosus+2 more
LiveKidney.Bio 10
Testing effectiveness (Phase 2)Study completedNCT00210327
What this trial is testing

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Who this might be right for
Lymphoma, Mucosa-Associated Lymphoid Tissue
International Extranodal Lymphoma Study Group (IELSG) 33
Not applicableStudy completedNCT05115370
What this trial is testing

Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19

Who this might be right for
Inflammatory DiseaseRheumatoid ArthritisPsoriatic Arthritis+5 more
University of Nottingham 20
Testing effectiveness (Phase 2)Looking for participantsNCT02991469
What this trial is testing

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 51
Large-scale testing (Phase 3)Looking for participantsNCT07444567
What this trial is testing

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Who this might be right for
AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
AstraZeneca 230
Not applicableActive Not RecruitingNCT06897722
What this trial is testing

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

Who this might be right for
Psoriasis (PsO)Periodontal Disease
Zhala Vatankha Sain 100
Testing effectiveness (Phase 2)Study completedNCT02141672
What this trial is testing

AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 265
Not applicableLooking for participantsNCT05807256
What this trial is testing

Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

Who this might be right for
Rheumatic DiseasesFertility DisordersPregnancy, High Risk+2 more
IRCCS San Raffaele 500
Large-scale testing (Phase 3)Study completedNCT03000439
What this trial is testing

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Who this might be right for
Arthritis Juvenile Idiopathic
Pfizer 100
Not applicableStudy completedNCT05747651
What this trial is testing

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

Who this might be right for
Systemic Lupus Erythematosus (SLE)
University Hospital, Brest 6
Testing effectiveness (Phase 2)Study completedNCT02969837
What this trial is testing

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 46
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Not applicableLooking for participantsNCT01241305
What this trial is testing

One-Time DNA Study for Vasculitis

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)+3 more
University of Pennsylvania 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03214666
What this trial is testing

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Who this might be right for
High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more
GT Biopharma, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT01777256
What this trial is testing

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 51
Next Page